Cosmo Bio CompanyLimited's (TSE:3386) Earnings Are Weaker Than They Seem
Cosmo Bio Company,Limited (TSE:3386) announced strong profits, but the stock was stagnant. We did some digging, and we found some concerning factors in the details.
The Impact Of Unusual Items On Profit
For anyone who wants to understand Cosmo Bio CompanyLimited's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from JP¥57m worth of unusual items. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's as you'd expect, given these boosts are described as 'unusual'. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).
Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Cosmo Bio CompanyLimited.
Our Take On Cosmo Bio CompanyLimited's Profit Performance
We'd posit that Cosmo Bio CompanyLimited's statutory earnings aren't a clean read on ongoing productivity, due to the large unusual item. Therefore, it seems possible to us that Cosmo Bio CompanyLimited's true underlying earnings power is actually less than its statutory profit. But at least holders can take some solace from the 45% EPS growth in the last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. If you want to do dive deeper into Cosmo Bio CompanyLimited, you'd also look into what risks it is currently facing. Our analysis shows 3 warning signs for Cosmo Bio CompanyLimited (1 can't be ignored!) and we strongly recommend you look at these before investing.
Today we've zoomed in on a single data point to better understand the nature of Cosmo Bio CompanyLimited's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.